Nice to see so many positive statements today.  Let's switch the epigentic breaker to soft pumping.  After all, we are supporting the company and the RVX share price.  Too bad retail sold off in the last hour today.  LED, could you not resist selling today?  The .40 price range today is just the starting point on the run up to the FA.

HL stock is listed in China and the USA.  Perhaps they will promote their RVX stock back home and also RVX, since they own so much.  Perhaps RVX should listed over there, is it Hongkong?, perhaps better than NASDEC.  The Chinese can then just buy us up and lift the share price.  Not much different than being listed in Germany.  If the Chinese start to eat like Westerner's, they may have to adopt our drugs which they already own 42% or so.

The other impetus I see for a large stock price move could occur at a sucessful FA if Zenith suddenly releases some ground-breaking results the next day.  The study is not blinded, and they can tailor their releases to help in their long expected stock listing.  The FA is 4 months away, my optomistic guess.  The longer the better for the apabetalone survivors, as the last adhoc survival curve that I saw (or vagley remember) for the placebo side looked a lot like the global warming hockey-stick curve as they approached the 6-month stage of the previous short trials.  A 14 to 15 month average trial length at the FA could be conclusive given the fine-tuned sellection of the volunteers.

JMHO - Absolutely